Vitruvias 30mg Thyroid Tablets Recalled — Now the FDA’s Highest Risk Level
If you or a family member takes Vitruvias Therapeutics’ Thyroid Tablets, USP 30 mg, check your bottle now. One lot may be stronger than labeled, and on September 22, 2026, the FDA classified this recall as Class I — its most serious risk category, meaning use of the product could reasonably cause serious health consequences…
